The use of histamine receptor antagonists for the reduction of intracranial pressure

The invention concerns the use of an H1- and/or H2-histamine receptor antagonist for the reduction of intracranial pressure (ICP), in particular for the prevention and treatment of elevated intracranial pressure and/or secondary ischaemia, in particular caused by brain injury, more in particular cau...

Ausführliche Beschreibung

Bibliographische Detailangaben

Hauptverfasser:	GOMEZ-SANCHEZ, ANTONIO, FERNANDEZ-GADEA, FRANCISCO, JAVIER, VAN REEMPTS, JOZEF, LEO, HENRI, TEGTMEIER, FRANK, LEENAERTS, JOSEPH, ELISABETH, BARTOLOME-NEBREDA, JOSE MANUEL, ALCAZAR-VACA, MANUEL, JESUS, VAN ROSSEM, KOENRAAD, ARTHUR, JANSSENS, FRANS, EDUARD, MARTINEZ-JIMENEZ, PEDRO
Format:	Patent
Sprache:	eng ; fre ; ger
Schlagworte:	CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!